| Authors: |
Izgutdina A; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA., Rashid T; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA., Temple WC; Department of Pediatrics, Division of Oncology, UCSF Benioff Children's Hospitals, University of California, San Francisco, San Francisco, CA.; Department of Pediatrics, Division of Allergy, Immunology, and Bone Marrow Transplantation, UCSF Benioff Children's Hospitals, University of California, San Francisco, San Francisco, CA., Patiño-Escobar B; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA., Walunj S; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA., Geng H; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA., Takamatsu H; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA.; Department of Hematology, Kanazawa University, Kanazawa, Japan., Gil-Alós D; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA.; Hospital Universitario 12 de Octubre-Centro Nacional de Investigaciones Oncológicas (H12O-CNIO) Haematological Malignancies Clinical Research Unit, Spanish National Cancer Research Centre, Madrid, Spain.; Department of Hematology, Hospital Universitario 12 de Octubre-Universidad Complutense, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), CIBERONC, Madrid, Spain., Kang AS; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA., Ramos E; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA., Chen SY; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA., Johnson H; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA., Nix MA; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA., Naik A; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA., Yuan CM; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD., Wang HW; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, Bethesda, MD., Aminov S; Department of Oncology, Blood Cancer Institute, Montefiore Einstein Comprehensive Cancer Center, Bronx, NY., Sahu S; Department of Oncology, Blood Cancer Institute, Montefiore Einstein Comprehensive Cancer Center, Bronx, NY., Larson RC; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA.; Harvard Medical School, Boston, MA., Carpenter C; Arc Institute, Palo Alto, CA., Salangsang F; Preclinical Therapeutics Core, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA., Phojanakong P; Preclinical Therapeutics Core, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA., Serrano JAC; Preclinical Therapeutics Core, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA., Tariq I; Preclinical Therapeutics Core, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA., Zakraoui O; Preclinical Therapeutics Core, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA., Steri V; Preclinical Therapeutics Core, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, CA., Valeri A; Hospital Universitario 12 de Octubre-Centro Nacional de Investigaciones Oncológicas (H12O-CNIO) Haematological Malignancies Clinical Research Unit, Spanish National Cancer Research Centre, Madrid, Spain.; Department of Hematology, Hospital Universitario 12 de Octubre-Universidad Complutense, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), CIBERONC, Madrid, Spain., Martinez-Lopez J; Hospital Universitario 12 de Octubre-Centro Nacional de Investigaciones Oncológicas (H12O-CNIO) Haematological Malignancies Clinical Research Unit, Spanish National Cancer Research Centre, Madrid, Spain.; Department of Hematology, Hospital Universitario 12 de Octubre-Universidad Complutense, Instituto de Investigación Sanitaria Hospital 12 de Octubre (imas12), CIBERONC, Madrid, Spain., Maus MV; Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA.; Harvard Medical School, Boston, MA.; Blood and Marrow Transplant Program, Massachusetts General Hospital, Boston, MA., Parekh S; Dept. of Medicine, Division of Hematology and Medical Oncology; Dept. of Oncological Sciences; and Precision Immunology Institute, Icahn School of Medicine at Mount Sinai, New York, NY., Verma A; Department of Oncology, Blood Cancer Institute, Montefiore Einstein Comprehensive Cancer Center, Bronx, NY., Shah NN; Pediatric Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD., Wiita AP; Department of Laboratory Medicine, University of California, San Francisco, San Francisco, CA.; Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco, CA.; Chan Zuckerberg Biohub San Francisco, San Francisco, CA.; Parker Institute for Cancer Immunotherapy, San Francisco, CA. |
